A culture medium and method for improving NK cell proliferation and killing activity in a serum-free environment

Through a three-stage culture medium scheme, the combination of specific ingredients is used to provide nutrition and stimulating factors at different stages, solving the problems of low efficiency and insufficient functional activity of NK cell amplification in a serum-free environment, significantly improving the killing activity of NK cells and Amplification efficiency provides efficient cellular preparations for tumor immunotherapy.

CN118620839BActive Publication Date: 2024-11-12SHANDONG BOSEN MEDICINE ENG TECH CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411102992.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-08-13
Publication Date
2024-11-12
Estimated Expiration
2044-08-13

AI Technical Summary

Technical Problem

The existing serum-free culture medium has low proliferation efficiency and insufficient cell functional activity in NK cell amplification, making it difficult to meet the needs of clinical applications.

Method used

A three-stage medium scheme was designed, including media A, B and C, to provide nutrition and stimulating factors at different stages, through N-acetylcysteine, shiitake polysaccharide, IL-2, ginseng saponin Rg1, Recombinant components such as human Flt3 ligand, forsythiatin and IL-21 are synergistically improved the amplification efficiency and killing activity of NK cells.

Benefits of technology

It significantly improves the amplification efficiency and killing activity of NK cells, significantly improves the killing rate of liver and lung cancer cells, avoids batch differences and potential contamination problems caused by serum culture media, and provides safer and more reliable cell preparations.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118620839B_ABST
    Figure CN118620839B_ABST
Patent Text Reader

Abstract

The present invention provides a culture medium and method for improving the proliferation and killing activity of NK cells in a serum-free environment, and belongs to the field of medical technology. The immune cells involved in the present invention are NK cells. By using three different culture media, culture medium A, culture medium B and culture medium C to provide specific nutrition and stimulation factors in the early, middle and final stages of NK cell culture, the present invention achieves the effect of significantly improving the NK cell proliferation multiple and the killing activity of tumor cells in a serum-free environment, especially in liver cancer and lung cancer cells. The present invention solves the problems of low proliferation efficiency and insufficient cell functional activity of traditional serum-free culture methods. Therefore, the present invention provides a safe and efficient NK cell culture scheme, which provides new technical support for tumor immunotherapy.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of medical technology, and in particular relates to a culture medium and a method for improving the proliferation and killing activity of NK cells in a serum-free environment. Background Art

[0002] In the field of modern medicine, immune cells, especially natural killer (NK) cells, play an important role in anti-cancer and antiviral treatment. As an important component of the immune system, NK cells can play a key role by identifying and killing infected cells and tumor cells. In recent years, with the rapid development of immunotherapy, the in vitro culture and expansion technology of NK cells has received widespread attention.

[0003] However, the content of NK cells in peripheral blood is relatively low, accounting for about 5-15% of lymphocytes. In immunotherapy applications, a large number of functionally active NK cells are required, which places high demands on in vitro expansion technology. Traditional culture methods usually rely on serum culture media. Although these culture media provide rich nutrients, they also bring challenges such as batch-to-batch differences, potential contamination and ethical issues. Therefore, it is particularly important to develop a serum-free culture medium to meet the needs of clinical applications.

[0004] At present, the application of serum-free medium in NK cell expansion has made some progress, but there are still problems such as low proliferation efficiency and insufficient cell function activity. Therefore, designing a serum-free medium that can significantly improve the proliferation efficiency and cell function of NK cells is a key issue that needs to be solved at present. Summary of the invention

[0005] The purpose of the present invention is to provide a culture medium and method for improving the proliferation and killing activity of NK cells in a serum-free environment to achieve rapid proliferation of NK cells and improve the killing activity of NK cells.

[0006] To achieve the above object, the present invention provides the following technical solutions:

[0007] First, the present invention provides a culture medium for improving the proliferation and killing activity of NK cells in a serum-free environment, wherein the culture medium is composed of the following culture medium A, culture medium B and culture medium C:

[0008] The culture medium A consists of N-acetylcysteine, lentinan, IL-2, taurine, dextran 40 and X-VIVO15 culture medium;

[0009] The culture medium B consists of ginsenoside Rg1, resveratrol, IL-15, taurine, dextran 40 and X-VIVO15 culture medium;

[0010] The culture medium C consists of recombinant human Flt3 ligand, forsythin, IL-21, taurine, dextran 40 and X-VIVO15 culture medium.

[0011] Preferably, in the culture medium A, the concentration of N-acetylcysteine ​​is 15-20 μg / L, the concentration of lentinan is 10-12 mg / L, the concentration of IL-2 is 80-100 μg / L, the concentration of taurine is 20-25 mg / L, and the concentration of dextran 40 is 5-8 mg / L.

[0012] Preferably, in the culture medium A, the concentration of N-acetylcysteine ​​is 20 μg / L, the concentration of lentinan is 10 mg / L, the concentration of IL-2 is 100 μg / L, the concentration of taurine is 25 mg / L, and the concentration of dextran 40 is 5 mg / L.

[0013] Preferably, in the culture medium B, the concentration of ginsenoside Rg1 is 12-15 mg / L, the concentration of resveratrol is 12-15 mg / L, the concentration of IL-15 is 50-75 μg / L, the concentration of taurine is 20-25 mg / L, and the concentration of dextran 40 is 5-8 mg / L.

[0014] Preferably, in the culture medium B, the concentration of ginsenoside Rg1 is 15 mg / L, the concentration of resveratrol is 12 mg / L, the concentration of IL-15 is 75 μg / L, the concentration of taurine is 25 mg / L, and the concentration of dextran 40 is 5 mg / L.

[0015] Preferably, in the culture medium C, the concentration of the recombinant human Flt3 ligand is 20-25 μg / L, the concentration of forsythin is 8-12 mg / L, the concentration of IL-21 is 35-40 μg / L, the concentration of taurine is 30-35 mg / L, and the concentration of dextran 40 is 8-10 mg / L.

[0016] Preferably, in the culture medium C, the concentration of the recombinant human Flt3 ligand is 25 μg / L, the concentration of forsythin is 10 mg / L, the concentration of IL-21 is 40 μg / L, the concentration of taurine is 35 mg / L, and the concentration of dextran 40 is 8 mg / L.

[0017] Preferably, the killing activity is the activity of killing tumor cells.

[0018] Secondly, the present invention provides a method for improving the proliferation and killing activity of NK cells in a serum-free environment, the method comprising the following steps:

[0019] (a) The obtained NK cells were prepared into a cell suspension of 1×10^6 cells / mL using medium A and cultured for 2 days;

[0020] (b) Change to medium B, adjust the cell density to 1×10^6 cells / mL, and continue culturing;

[0021] (c) On days 5 and 7, medium B was added to adjust the cell density to 1×10^6 cells / mL and the culture was continued;

[0022] (d) On day 9, the medium was changed to medium C, the cell density was adjusted to 1×10^6 cells / mL, and the culture was continued;

[0023] (e) On day 11, medium C was added to adjust the cell density to 1×10^6 cells / mL and the culture was continued;

[0024] (f) The culture was terminated on day 12 and NK cells were collected.

[0025] Preferably, the culture medium A consists of 15-20 μg / L N-acetylcysteine, 10-12 mg / L lentinan, 80-100 μg / L IL-2, 20-25 mg / L taurine, 5-8 mg / L dextran 40 and X-VIVO 15 culture medium;

[0026] The culture medium B consists of 12-15 mg / L ginsenoside Rg1, 12-15 mg / L resveratrol, 50-75 μg / L IL-15, 20-25 mg / L taurine, 5-8 mg / L dextran 40 and X-VIVO 15 culture medium;

[0027] The culture medium C consists of 20-25 μg / L recombinant human Flt3 ligand, 8-12 mg / L forsythiaside, 35-40 μg / L IL-21, 30-35 mg / L taurine, 8-10 mg / L dextran 40 and X-VIVO 15 culture medium.

[0028] Preferably, the culture medium A consists of 20 μg / L N-acetylcysteine, 10 mg / L lentinan, 100 μg / L IL-2, 25 mg / L taurine, 5 mg / L dextran 40 and X-VIVO 15 culture medium;

[0029] The culture medium B consists of 15 mg / L ginsenoside Rg1, 12 mg / L resveratrol, 75 μg / L IL-15, 25 mg / L taurine, 5 mg / L dextran 40 and X-VIVO 15 culture medium;

[0030] The culture medium C consists of 25 μg / L recombinant human Flt3 ligand, 10 mg / L forsythiaside, 40 μg / L IL-21, 35 mg / L taurine, 8 mg / L dextran 40 and X-VIVO 15 culture medium.

[0031] Preferably, the killing activity is the activity of killing tumor cells, and the tumor cells include liver cancer cells and lung cancer cells.

[0032] Secondly, the present invention provides a NK cell with high proliferation ability and high tumor killing activity, wherein the NK cell is cultured by the above-mentioned method for improving NK cell proliferation and killing activity, and the tumor is liver cancer or lung cancer.

[0033] Finally, the present invention provides a cell preparation for treating tumors, the cell preparation comprising NK cells and physiological saline, the NK cells being cultured by the above-mentioned method for improving the proliferation and killing activity of NK cells, and the tumor being liver cancer or lung cancer;

[0034] In the cell preparation, the amount of NK cells contained in each 1 ml of physiological saline is 1×10^6 cells.

[0035] The beneficial effects of the present invention are:

[0036] 1. The three-stage culture medium provided by the present invention, including culture medium A, culture medium B and culture medium C, meets the needs of NK cells at different growth stages by providing specific nutrients and stimulating factors at different stages, and synergistically improves the expansion efficiency of NK cells.

[0037] 2. By adopting the three-stage culture method of the present invention, the killing activity of NK cells against liver cancer and lung cancer cells is significantly improved. Specific data show that compared with the comparative example, the killing rate of NK cells cultured by the method of the present invention is significantly improved, showing a stronger tumor killing ability.

[0038] 3. The present invention adopts serum-free culture medium, which not only avoids the batch-to-batch differences and potential contamination problems caused by serum culture medium, but also meets ethical requirements. This provides a safer and more reliable culture environment for the clinical application of NK cells.

[0039] 4. By optimizing the proliferation and function of NK cells, their ability to kill tumor cells is significantly improved, providing an efficient cell preparation for tumor immunotherapy. The optimization of this culture strategy provides a new and effective cell culture solution for future tumor immunotherapy.

[0040] 5. Experiments have shown that NK cells cultured using the three-stage culture method provided by the present invention exhibit strong killing ability against both liver cancer and lung cancer cells. This shows that the culture medium of the present invention is universal and effective in enhancing the killing activity of NK cells. BRIEF DESCRIPTION OF THE DRAWINGS

[0041] Figure 1 The killing activity of NK cells cultured by different methods on liver cancer cells;

[0042] Figure 2 The cytotoxic activity of NK cells cultured by different methods on lung cancer cells. DETAILED DESCRIPTION

[0043] Example 1: A culture medium for improving NK cell proliferation and killing activity in a serum-free environment

[0044] The culture medium consists of the following culture medium A, culture medium B and culture medium C;

[0045] Among them, culture medium A consists of: 20 μg / L N-acetylcysteine, 10 mg / L Lentinan, 100 μg / L IL-2, 25 mg / L taurine, 5 mg / L dextran 40 and X-VIVO 15 culture medium.

[0046] Medium B consisted of: 15 mg / L ginsenoside Rg1, 12 mg / L resveratrol, 75 μg / L IL-15, 25 mg / L taurine, 5 mg / L dextran 40 and X-VIVO 15 medium.

[0047] Medium C consisted of: 25 μg / L recombinant human Flt3 ligand (FLT3-L), 10 mg / L forsythiaside, 40 μg / L IL-21, 35 mg / L taurine, 8 mg / L dextran 40 and X-VIVO 15 medium.

[0048] Example 2: A culture medium for improving NK cell proliferation and killing activity in a serum-free environment

[0049] The culture medium consists of the following culture medium A, culture medium B and culture medium C;

[0050] Among them, culture medium A consists of: 15 μg / L N-acetylcysteine, 12 mg / L Lentinan, 80 μg / L IL-2, 20 mg / L taurine, 8 mg / L dextran 40 and X-VIVO 15 culture medium.

[0051] Medium B consisted of: 12 mg / L ginsenoside Rg1, 15 mg / L resveratrol, 50 μg / L IL-15, 20 mg / L taurine, 8 mg / L dextran 40 and X-VIVO 15 medium.

[0052] Medium C consists of: 20 μg / L recombinant human Flt3 ligand (FLT3-L), 8 mg / L forsythiaside, 40 μg / L IL-21, 35 mg / L taurine, 10 mg / L dextran 40 and X-VIVO 15 medium.

[0053] Example 3: A culture medium for improving NK cell proliferation and killing activity in a serum-free environment

[0054] The culture medium consists of the following culture medium A, culture medium B and culture medium C;

[0055] Among them, culture medium A consists of: 18 μg / L N-acetylcysteine, 12 mg / L Lentinan, 90 μg / L IL-2, 20 mg / L taurine, 6 mg / L dextran 40 and X-VIVO 15 culture medium.

[0056] Medium B consisted of: 12 mg / L ginsenoside Rg1, 12 mg / L resveratrol, 70 μg / L IL-15, 20 mg / L taurine, 6 mg / L dextran 40 and X-VIVO 15 medium.

[0057] Medium C consists of: 20 μg / L recombinant human Flt3 ligand (FLT3-L), 12 mg / L forsythiaside, 35 μg / L IL-21, 30 mg / L taurine, 8 mg / L dextran 40 and X-VIVO 15 medium.

[0058] Example 4: Obtaining NK cells

[0059] 1. Preliminary processing of peripheral blood samples

[0060] Take 30 ml of peripheral blood from healthy volunteers and place it in a 50 ml centrifuge tube;

[0061] Centrifuge at 800 g for 10 min at room temperature. Carefully aspirate the upper plasma layer and retain the cell layer.

[0062] Dilute the remaining cell layer with an equal volume of saline (1:1) and mix gently.

[0063] 2. Lymphocyte Isolation

[0064] Carefully layer the diluted blood sample onto the upper layer of the lymphocyte separation solution, taking care not to damage the separation solution interface;

[0065] After centrifugation at 2000 rpm for 20 minutes at room temperature, the buffy coat layer (peripheral blood mononuclear cells) was carefully aspirated and transferred to a new centrifuge tube.

[0066] 3. Washing and Resuspension

[0067] Wash three times with saline at room temperature, centrifuge at 800 g for 10 min each time, discard the supernatant after each centrifugation, and keep the cell pellet;

[0068] After the final wash, the cells were resuspended in X-VIVO 15 medium.

[0069] 4. Magnetic bead sorting

[0070] Using EasySep TM NK cells were isolated by human NK cell immunomagnetic bead sorting.

[0071] Example 5: A method for improving NK cell proliferation and killing activity in a serum-free environment

[0072] 1. The NK cells obtained according to the method of Example 4 were prepared into a cell suspension of 1×10^6 cells / mL using culture medium A (Example 1);

[0073] 2. Inoculate 10 mL of cell suspension into a culture dish and place it in an incubator at 37°C and 5% CO2;

[0074] 3. After culturing for 2 days, the medium was replaced with medium B (Example 1), the cell density was adjusted to 1×10^6 cells / mL, and the cells were placed in an incubator at 37°C and 5% CO2 for further culturing;

[0075] 4. On the 5th and 7th days, medium B (Example 1) was supplemented to adjust the cell density to 1×10^6 cells / mL, and the cells were placed in an incubator at 37°C and 5% CO2 for further culture;

[0076] 5. On the 9th day, replace with medium C, adjust the cell density to 1×106 cells / mL, and continue culturing in an incubator at 37°C and 5% CO2;

[0077] 6. On the 11th day, supplement medium C (Example 1), adjust the cell density to 1×10^6 cells / mL, and continue culturing in an incubator at 37°C and 5% CO2;

[0078] 7. On day 12, terminate the culture and collect NK cells for subsequent experiments.

[0079] Example 6: A method for improving NK cell proliferation and killing activity in a serum-free environment

[0080] 1. The NK cells obtained according to the method of Example 4 were prepared into 1×10 6 cells / mL of cell suspension;

[0081] 2. Inoculate 10 mL of cell suspension into a culture dish and place it in an incubator at 37°C and 5% CO2;

[0082] 3. After culturing for 2 days, the medium was replaced with medium B (Example 2), the cell density was adjusted to 1×10^6 cells / mL, and the cells were placed in an incubator at 37°C and 5% CO2 for further culturing;

[0083] 4. On the 5th and 7th days, medium B was added to adjust the cell density to 1×10^6 cells / mL, and the cells were cultured in an incubator at 37°C and 5% CO2.

[0084] 5. On the 9th day, the medium was replaced with medium C (Example 2), the cell density was adjusted to 1×10^6 cells / mL, and the cells were placed in an incubator at 37°C and 5% CO2 for further culture;

[0085] 6. On the 11th day, supplement medium C, adjust the cell density to 1×10^6 cells / mL, and continue culturing in an incubator at 37°C and 5% CO2;

[0086] 7. On day 12, terminate the culture and collect NK cells for subsequent experiments.

[0087] Example 7: A method for improving NK cell proliferation and killing activity in a serum-free environment

[0088] 1. The NK cells obtained according to the method of Example 4 were prepared into 1×10 6 cells / mL of cell suspension;

[0089] 2. Inoculate 10 mL of cell suspension into a culture dish and place it in an incubator at 37°C and 5% CO2;

[0090] 3. After culturing for 2 days, the medium was replaced with medium B (Example 3), the cell density was adjusted to 1×10^6 cells / mL, and the cells were placed in an incubator at 37°C and 5% CO2 for further culturing;

[0091] 4. On the 5th and 7th days, medium B was added to adjust the cell density to 1×10^6 cells / mL, and the cells were cultured in an incubator at 37°C and 5% CO2.

[0092] 5. On the 9th day, the medium was replaced with medium C (Example 3), the cell density was adjusted to 1×10^6 cells / mL, and the cells were placed in an incubator at 37°C and 5% CO2 for further culture;

[0093] 6. On the 11th day, supplement medium C, adjust the cell density to 1×10^6 cells / mL, and continue culturing in an incubator at 37°C and 5% CO2;

[0094] 7. On day 13, terminate the culture and collect NK cells.

[0095] Comparative Example 1: NK cells were cultured using the culture medium A in Example 1, and the culture medium A was replenished every 2 days. The cell density was adjusted to 1×10^6 cells / mL and cultured in an incubator at 37°C and 5% CO2. After 12 days of culture, the culture was terminated and the NK cells were collected.

[0096] Comparative Example 2: NK cells were cultured using culture medium B in Example 1, and culture medium A was supplemented every 2 days. The cell density was adjusted to 1×10^6 cells / mL and cultured in an incubator at 37°C and 5% CO2. After 12 days of culture, the culture was terminated and the NK cells were collected.

[0097] Comparative Example 3: NK cells were cultured using culture medium C in Example 1, and culture medium A was supplemented every 2 days. The cell density was adjusted to 1×10^6 cells / mL and cultured in an incubator at 37°C and 5% CO2. After 12 days of culture, the culture was terminated and the NK cells were collected.

[0098] Comparative Example 4: NK cells were cultured using the medium A in Example 1 for 1-6 days, the medium A was replenished every 2 days, the cell density was adjusted to 1×10^6 cells / mL, and the cells were cultured in an incubator at 37°C and 5% CO2;

[0099] 7-12 days culturing NK cells in the medium B of Experimental Example 1, replenishing the medium B every 2 days, and culturing in an incubator at 37° C. and 5% CO 2 ;

[0100] After 12 days of culture, the culture was terminated and NK cells were collected.

[0101] Comparative Example 5: NK cells were cultured using the medium A in Example 1 for 1-6 days, the medium A was replenished once a day, the cell density was adjusted to 1×10^6 cells / mL, and the cells were cultured in an incubator at 37°C and 5% CO2;

[0102] 7-12 days: NK cells were cultured in the medium C of Experimental Example 1, and the medium B was supplemented every 2 days to adjust the cell density to 1×10^6 cells / mL, and cultured in an incubator at 37° C. and 5% CO2;

[0103] After 12 days of culture, the culture was terminated and NK cells were collected.

[0104] Comparative Example 6: NK cells were cultured using the medium B in Example 1 for 1-6 days, the medium B was replenished once a day, the cell density was adjusted to 1×10^6 cells / mL, and the cells were cultured in an incubator at 37°C and 5% CO2;

[0105] 7-12 days: culturing NK cells in the medium C of Experimental Example 1, replenishing the medium C every 2 days, adjusting the cell density to 1×10^6 cells / mL, and culturing in an incubator at 37° C. and 5% CO 2 ;

[0106] After 12 days of culture, the culture was terminated and NK cells were collected.

[0107] Detection method and test results 1:

[0108] Expansion multiples of NK cells cultured by different culture methods

[0109] 1. Prepare the NK cells obtained in Examples 5-7 and Comparative Examples 1-6 into a cell suspension, and take 10 μL of the cell suspension and place it in a sterile centrifuge tube;

[0110] 2. Add 10 µL of 0.4% trypan blue staining solution to the centrifuge tube and mix the staining solution and cell suspension in a 1:1 ratio;

[0111] 3. After gently mixing, incubate at room temperature for 2 minutes, take 10 µL of the stained cell suspension and carefully add it to the counting chamber of the hemocytometer, making sure that the droplets are evenly distributed throughout the counting chamber;

[0112] 4. Under a microscope, count the cells and calculate the total number of cells. The results are shown in Table 1.

[0113] Table 1 Expansion times of NK cells cultured by different culture methods

[0114]

[0115] From the results in Table 1, it can be seen that the amplification effect of the embodiment is:

[0116] The amplification effect of Example 5 was the best, with an amplification multiple of 337 and a final total number of amplified cells of 3.37×10^9; the amplification effects of Example 6 and Example 7 were also very significant, with amplification multiples of 315 and 322, respectively, and a final total number of amplified cells of 3.15×10^9 and 3.22×10^9, respectively.

[0117] Amplification effect of comparative ratio:

[0118] The expansion times of Comparative Examples 1, 2 and 3 were 31.30, 39.40 and 25.80 respectively, which were significantly lower than those of the embodiment. This indicates that the effect of a single culture medium in promoting NK cell expansion is limited and cannot achieve an ideal expansion effect.

[0119] The amplification multiples of Comparative Examples 4, 5 and 6 were 86.10, 75.70 and 69.60 respectively, which were better than Comparative Examples 1, 2 and 3, but still significantly lower than the embodiment. Although slightly better than Comparative Examples 1, 2 and 3, there was still a significant gap compared with the embodiment. This further shows that even if a combined culture medium is used, if the three culture media are not coordinated and the three-stage culture method is not followed, the amplification effect is still difficult to achieve the expected effect.

[0120] By comparing the expansion effects of the embodiments and the comparative examples, it can be clearly seen that the three-stage culture using the culture medium provided by the present invention has a significant synergistic effect on the expansion of NK cells in a serum-free environment. Therefore, the culture medium and three-stage culture strategy of the present invention provide an efficient and reliable method for the in vitro expansion of NK cells, which has important clinical application prospects.

[0121] Detection method and test results 2:

[0122] Cytotoxic activity of NK cells cultured by different methods against liver cancer cells

[0123] 1. Tumor Cell Preparation

[0124] (1) Cultivate HepG2 liver cancer cells in a culture flask until the logarithmic growth phase to ensure that the cells grow well and are not over-fused;

[0125] (2) Digest the cells with trypsin (0.25% trypsin-EDTA). Once the cells become round, add complete culture medium to neutralize the trypsin.

[0126] (3) Transfer the cell suspension to a centrifuge tube, centrifuge at 1000 rpm for 5 minutes, and discard the supernatant;

[0127] (4) Resuspend the cells in an appropriate amount of culture medium, count using a cell counting plate, and adjust the cell concentration to 1×10^5 cells / mL;

[0128] (5) Aliquot the cell suspension into a 96-well plate and add 100 μL of cell suspension to each well (i.e., 1×10^4 cells per well);

[0129] (6) Place the 96-well plate in a 37°C, 5% CO2 incubator and culture for 24 hours or until the cells are completely attached.

[0130] 2. NK Cell Preparation

[0131] (1) The NK cells cultured according to Example 5, Comparative Example 1, Comparative Example 2, Comparative Example 3, Comparative Example 4, Comparative Example 5 and Comparative Example 6 were prepared into 1×10^6 cells / mL using a culture medium (since Experimental Example 5 has proved that the effect of Example 5 is the best, this Experimental Example only uses Example 5 for the experiment);

[0132] 3. Cell Co-culture

[0133] (1) After the tumor cells adhere to the wall, carefully aspirate the culture medium and add 100 μL of the above-mentioned NK cell suspension;

[0134] (2) A blank control group was set up, with only 100 μL of tumor cell suspension added to each well without NK cells;

[0135] (3) For the negative control group, only 100 μL of culture medium was added to each well without adding cells. Three replicate wells were set up for each treatment group to ensure the reliability of the experimental data.

[0136] 4. Incubation

[0137] Place the 96-well plate in a 37°C, 5% CO2 incubator and incubate for 4 hours.

[0138] 5.CCK-8 assay

[0139] (1) After the incubation, remove the original culture medium and add the culture medium containing CCK-8 reagent. Mix carefully to avoid bubbles.

[0140] (2) The 96-well plate was placed in the incubator for another 3 hours. The optical density (OD value) of each well was measured at 450 nm using a microplate reader to calculate the killing rate:

[0141] Killing rate (%) = OD value of blank control group − OD value of experimental group / OD value of blank control group × 100%.

[0142] The results are as follows Figure 1 And as shown in Table 2.

[0143] Table 2 Cytotoxicity of NK cells cultured by different methods against liver cancer cells

[0144]

[0145] From Table 2 and Figure 1 It can be seen that among Comparative Examples 1, 2, and 3 using culture medium A, culture medium B, and culture medium C respectively, Comparative Example 3 has the best effect in promoting NK cell killing activity, indicating that culture medium C can more effectively promote NK cell killing activity;

[0146] Further observation revealed that in Comparative Examples 4, 5 and 6, the effect of Comparative Example 4 using the combination of Culture Medium A and Culture Medium B was not significantly improved, while the effect of Comparative Example 5 using the combination of Culture Medium A and Culture Medium C and Comparative Example 6 using the combination of Culture Medium B and Culture Medium C was improved compared to using Culture Medium C alone, but the improved effect was relatively limited.

[0147] It is particularly noteworthy that the three-stage culture method used in Example 1, i.e., the use of culture medium A, culture medium B and culture medium C, significantly improved the killing rate of NK cells against liver cancer cells HepG2. Specific data show that compared with the worst comparative example 2, the killing rate of Example 1 increased by 78.89%; compared with the best comparative example 5, its killing rate also increased by 34.05%. This result highlights the significant advantages of the three-stage culture method in improving the killing ability of NK cells.

[0148] It can be seen from the above results that under the same culture conditions and time, the three-stage culture method using the culture medium A, culture medium B and culture medium C provided by the present invention can significantly improve the effect of NK cells in killing liver cancer cells HepG2.

[0149] Detection method and test results 3:

[0150] 1. Tumor Cell Preparation

[0151] (1) Cultivate lung cancer A549 cells in a culture flask until the logarithmic growth phase to ensure that the cells grow well and are not over-confluent;

[0152] (2) Digest the cells with trypsin (0.25% trypsin-EDTA). Once the cells become round, add complete culture medium to neutralize the trypsin.

[0153] (3) Transfer the cell suspension to a centrifuge tube, centrifuge at 1000 rpm for 5 minutes, and discard the supernatant;

[0154] (4) Resuspend the cells in an appropriate amount of culture medium, count using a cell counting plate, and adjust the cell concentration to 1×10^5 cells / mL;

[0155] (5) Aliquot the cell suspension into a 96-well plate and add 100 μL of cell suspension to each well (i.e., 1×10^4 cells per well);

[0156] (6) Place the 96-well plate in a 37°C, 5% CO2 incubator and culture for 24 hours or until the cells are completely attached.

[0157] 2. NK Cell Preparation

[0158] (1) The NK cells cultured according to Example 5, Comparative Example 1, Comparative Example 2, Comparative Example 3, Comparative Example 4, Comparative Example 5 and Comparative Example 6 were prepared into 1×10^6 cells using a culture medium;

[0159] 3. Cell Co-culture

[0160] (1) After the tumor cells adhere to the wall, carefully aspirate the culture medium and add 100 μL of the above-mentioned NK cell suspension;

[0161] (2) A blank control group was set up, with only 100 μL of tumor cell suspension added to each well without NK cells;

[0162] (3) For the negative control group, only 100 μL of culture medium was added to each well without adding cells. Three replicate wells were set up for each treatment group to ensure the reliability of the experimental data.

[0163] 4. Incubation

[0164] Place the 96-well plate in a 37°C, 5% CO2 incubator and incubate for 4 hours.

[0165] 5.CCK-8 assay

[0166] (1) After the incubation, remove the original culture medium and add the culture medium containing CCK-8 reagent. Mix carefully to avoid bubbles.

[0167] (2) The 96-well plate was placed in the incubator for another 3 hours. The optical density (OD value) of each well was measured at 450 nm using a microplate reader to calculate the killing rate:

[0168] Killing rate (%) = OD value of blank control group − OD value of experimental group / OD value of blank control group × 100%.

[0169] The results are as follows Figure 2 And as shown in Table 3.

[0170] Table 3 Cytotoxicity of NK cells cultured by different methods against lung cancer cells

[0171]

[0172] Through careful analysis Figure 2 From the data in Table 3, we can observe a significant phenomenon: in the killing experiment of lung cancer cells using NK cells obtained by different culture methods, the killing effect of Example 5 is significantly better than that of other comparative examples. Specifically, compared with the worst comparative example 2, the killing rate of Example 1 increased by 83.19%; and compared with the best comparative example 5, its killing rate also increased by 32.08%. This result was not only verified in the liver cancer cell killing experiment, but also repeated in the lung cancer cell experiment, indicating the universality and effectiveness of the culture method of Example 5 in improving the killing activity of NK cells.

[0173] Further combined with the results of Experimental Examples 2 and 3, we can find that the three-stage culture method provided by the present invention, that is, the combined culture of culture medium A, culture medium B and culture medium C, can significantly enhance the killing activity of NK cells against different types of tumor cells. This culture method not only performed well in the killing experiment of liver cancer cells, but also showed excellent results in the experiment of lung cancer cells. This shows that the three-stage culture method may optimize the biological characteristics of NK cells through a specific biological mechanism, so that it can exert a strong killing ability when facing different types of tumor cells.

[0174] In general, in the three-stage culture medium of the present invention, the combination of culture medium A, B, and C provides specific nutrients and stimulation factors at different stages to meet the needs of NK cells at different growth stages.

[0175] In this study, we used an innovative three-stage culture method to provide the necessary nutrients and stimulation at different stages of NK cell culture through carefully designed medium A, medium B, and medium C to achieve optimal cell proliferation and cytotoxic activity. The following is a detailed description of this method:

[0176] Medium A: Initial activation and basic proliferation

[0177] In the early stages of NK cell culture, medium A provides key activation and proliferation conditions. Among them, N-acetylcysteine ​​protects the initially cultured cells from damage by reducing oxidative stress. Lentinan significantly increases the activity of NK cells by activating them. IL-2, as an important cytokine, promotes the proliferation of NK cells. Taurine plays a role in maintaining cell osmotic pressure and enhancing cell water retention at this stage, while dextran 40 supports initial cell proliferation by enhancing cell stability.

[0178] Medium B: Medium-term enhanced cell proliferation and activity

[0179] In the mid-stage, medium B further enhanced the proliferation and activity of NK cells. Ginsenoside Rg1 promoted further cell proliferation and activity by regulating cell signaling pathways. Resveratrol provided anti-inflammatory and antioxidant protection, helping to prevent cell aging damage. IL-15, as an important cytokine, further enhanced the proliferation and activity of NK cells. Taurine and dextrose 40 continued to play their roles in maintaining cell osmotic pressure and enhancing cell stability at this stage, supporting mid-stage cell proliferation.

[0180] Medium C: Final expansion and activation of killing activity

[0181] In the final stage of culture, medium C promoted the final expansion of NK cells and the activation of cytotoxic activity. Recombinant human Flt3 ligand (FLT3-L) played a key role in this stage, promoting the final expansion and functional improvement of NK cells. Forsythiaside enhanced the cytotoxic activity of NK cells and supported the health of cells in the later stage. IL-21, as an important cytokine, enhanced the tumoricidal activity of cells and improved the function of NK cells. Taurine and dextrose 40 continued to play their role in maintaining cell osmotic pressure and enhancing cell stability at this stage, supporting the final cell expansion.

[0182] Through this three-stage culture method, the present invention achieves the synergistic promotion of NK cell proliferation and killing activity in the absence of serum. This method not only improves the proliferation efficiency of NK cells, but also significantly enhances their ability to kill tumor cells. The optimization of this culture strategy provides a new and effective cell culture scheme for future tumor immunotherapy.

Claims

1. A culture medium for improving the proliferation and killing activity of NK cells in a serum-free environment, It is characterized in that The culture medium consists of the following culture medium A, culture medium B and culture medium C: The culture medium A consists of N-acetylcysteine, lentinan, IL-2, taurine, dextran 40 and X-VIVO 15 culture medium; The culture medium B consists of ginsenoside Rg1, resveratrol, IL-15, taurine, dextran 40 and X-VIVO 15 culture medium; The culture medium C consists of recombinant human Flt3 ligand, forsythin, IL-21, taurine, dextran 40 and X-VIVO 15 culture medium; In the culture medium A, the concentration of N-acetylcysteine ​​is 15-20 μg / L, the concentration of lentinan is 10-12 mg / L, the concentration of IL-2 is 80-100 μg / L, the concentration of taurine is 20-25 mg / L, and the concentration of dextran 40 is 5-8 mg / L; In the culture medium B, the concentration of ginsenoside Rg1 is 12-15 mg / L, the concentration of resveratrol is 12-15 mg / L, the concentration of IL-15 is 50-75 μg / L, the concentration of taurine is 20-25 mg / L, and the concentration of dextran 40 is 5-8 mg / L; In the culture medium C, the concentration of the recombinant human Flt3 ligand is 20-25 μg / L, the concentration of the forsythin is 8-12 mg / L, the concentration of the IL-21 is 35-40 μg / L, the concentration of the taurine is 30-35 mg / L, and the concentration of the dextran 40 is 8-10 mg / L; The killing activity is the activity of killing tumor cells, and the tumor cells include liver cancer cells and lung cancer cells.

2. A method for improving the proliferation and killing activity of NK cells in a serum-free environment, It is characterized in that The method comprises the following steps: (a) The obtained NK cells were prepared into a cell suspension of 1×10^6 cells / mL using medium A and cultured for 2 days; (b) Change to medium B, adjust the cell density to 1×10^6 cells / mL, and continue culturing; (c) On days 5 and 7, medium B was added to adjust the cell density to 1×10^6 cells / mL and the culture was continued; (d) On day 9, the medium was changed to medium C, the cell density was adjusted to 1×10^6 cells / mL, and the culture was continued; (e) On day 11, medium C was added to adjust the cell density to 1×10^6 cells / mL and the culture was continued; (f) The culture was terminated on day 12 and NK cells were collected; The culture medium A consists of 15-20 μg / L N-acetylcysteine, 10-12 mg / L lentinan, 80-100 μg / L IL-2, 20-25 mg / L taurine, 5-8 mg / L dextran 40 and X-VIVO 15 culture medium; The culture medium B consists of 12-15 mg / L ginsenoside Rg1, 12-15 mg / L resveratrol, 50-75 μg / L IL-15, 20-25 mg / L taurine, 5-8 mg / L dextran 40 and X-VIVO 15 culture medium; The culture medium C consists of 20-25 μg / L recombinant human Flt3 ligand, 8-12 mg / L forsythiaside, 35-40 μg / L IL-21, 30-35 mg / L taurine, 8-10 mg / L dextran 40 and X-VIVO 15 culture medium; The killing activity is the activity of killing tumor cells, and the tumor cells include liver cancer cells and lung cancer cells.